Benjamin Burnett
Stock Analyst at Wells Fargo
(0.65)
# 3,859
Out of 4,382 analysts
383
Total ratings
39.4%
Success rate
-2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Benjamin Burnett
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintained: Buy | $160 | $94.22 | +69.82% | 7 | Jun 4, 2026 | |
| LQDA Liquidia | Maintained: Buy | $62 | $61.85 | +0.24% | 3 | Jun 4, 2026 | |
| MNKD MannKind | Maintained: Buy | $11 | $3.40 | +223.53% | 6 | Jun 2, 2026 | |
| XENE Xenon Pharmaceuticals | Maintained: Buy | $69 | $51.73 | +33.38% | 10 | Jun 1, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Hold | $305 → $323 | $254.00 | +27.17% | 5 | Jun 1, 2026 | |
| ALKS Alkermes | Maintained: Buy | $44 | $42.80 | +2.80% | 9 | May 26, 2026 | |
| SVRA Savara | Rated: Buy | $9 | $5.09 | +76.82% | 5 | May 22, 2026 | |
| WVE Wave Life Sciences | Rated: Buy | $13 → $14 | $5.73 | +144.33% | 7 | May 20, 2026 | |
| KROS Keros Therapeutics | Maintained: Buy | $23 → $20 | $10.30 | +94.17% | 4 | May 15, 2026 | |
| AMPH Amphastar Pharmaceuticals | Downgraded: Hold | $19 | $19.74 | -3.75% | 1 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $29.00 | +248.28% | 2 | May 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $575 → $738 | $549.87 | +34.21% | 8 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $47 | $21.91 | +114.51% | 7 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $202 → $255 | $232.32 | +9.76% | 6 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $46 | $36.10 | +27.42% | 3 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $35 → $42 | $39.62 | +6.01% | 5 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $86 | $70.97 | +21.18% | 5 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $78 → $64 | $149.23 | n/a | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $13 | $3.25 | n/a | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.58 | n/a | 19 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $4.23 | n/a | 33 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.5 → $4 | $1.88 | n/a | 23 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $3 | $9.92 | n/a | 30 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $3 | $1.98 | n/a | 23 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $94 → $92 | $67.00 | n/a | 21 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $0.4927 | n/a | 7 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53 → $49 | $51.84 | n/a | 23 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $66 → $64 | $28.29 | n/a | 20 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $0.0002 | n/a | 15 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $6.50 | n/a | 11 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.9 → $3.6 | $0.215 | n/a | 12 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4.7 → $3 | $57.32 | n/a | 12 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.5 | $26.49 | n/a | 3 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.7 → $0.16 | $0.0001 | n/a | 9 | Apr 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 → $120 | $29.40 | n/a | 2 | Feb 28, 2022 |
Insmed
Jun 4, 2026
Maintained: Buy
Price Target: $160
Current: $94.22
Upside: +69.82%
Liquidia
Jun 4, 2026
Maintained: Buy
Price Target: $62
Current: $61.85
Upside: +0.24%
MannKind
Jun 2, 2026
Maintained: Buy
Price Target: $11
Current: $3.40
Upside: +223.53%
Xenon Pharmaceuticals
Jun 1, 2026
Maintained: Buy
Price Target: $69
Current: $51.73
Upside: +33.38%
Praxis Precision Medicines
Jun 1, 2026
Maintained: Hold
Price Target: $305 → $323
Current: $254.00
Upside: +27.17%
Alkermes
May 26, 2026
Maintained: Buy
Price Target: $44
Current: $42.80
Upside: +2.80%
Savara
May 22, 2026
Rated: Buy
Price Target: $9
Current: $5.09
Upside: +76.82%
Wave Life Sciences
May 20, 2026
Rated: Buy
Price Target: $13 → $14
Current: $5.73
Upside: +144.33%
Keros Therapeutics
May 15, 2026
Maintained: Buy
Price Target: $23 → $20
Current: $10.30
Upside: +94.17%
Amphastar Pharmaceuticals
May 14, 2026
Downgraded: Hold
Price Target: $19
Current: $19.74
Upside: -3.75%
May 10, 2026
Maintained: Buy
Price Target: $101
Current: $29.00
Upside: +248.28%
May 7, 2026
Upgraded: Buy
Price Target: $575 → $738
Current: $549.87
Upside: +34.21%
May 6, 2026
Maintained: Buy
Price Target: $45 → $47
Current: $21.91
Upside: +114.51%
May 5, 2026
Rated: Buy
Price Target: $202 → $255
Current: $232.32
Upside: +9.76%
Apr 22, 2026
Maintained: Buy
Price Target: $46
Current: $36.10
Upside: +27.42%
Apr 20, 2026
Downgraded: Hold
Price Target: $35 → $42
Current: $39.62
Upside: +6.01%
Apr 13, 2026
Maintained: Buy
Price Target: $86
Current: $70.97
Upside: +21.18%
Apr 1, 2025
Maintained: Buy
Price Target: $78 → $64
Current: $149.23
Upside: n/a
Mar 31, 2025
Maintained: Buy
Price Target: $26 → $13
Current: $3.25
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $7
Current: $3.58
Upside: n/a
Mar 17, 2025
Maintained: Buy
Price Target: $18
Current: $4.23
Upside: n/a
Mar 17, 2025
Maintained: Hold
Price Target: $4.5 → $4
Current: $1.88
Upside: n/a
Mar 11, 2025
Maintained: Hold
Price Target: $5 → $3
Current: $9.92
Upside: n/a
Mar 6, 2025
Maintained: Hold
Price Target: $5 → $3
Current: $1.98
Upside: n/a
Mar 3, 2025
Maintained: Buy
Price Target: $94 → $92
Current: $67.00
Upside: n/a
Mar 2, 2025
Maintained: Buy
Price Target: $80
Current: $0.4927
Upside: n/a
Feb 13, 2025
Maintained: Hold
Price Target: $53 → $49
Current: $51.84
Upside: n/a
Nov 6, 2024
Maintained: Buy
Price Target: $66 → $64
Current: $28.29
Upside: n/a
Apr 19, 2024
Maintained: Buy
Price Target: $10
Current: $0.0002
Upside: n/a
Aug 16, 2023
Maintained: Buy
Price Target: $42
Current: $6.50
Upside: n/a
Aug 10, 2023
Maintained: Hold
Price Target: $3.9 → $3.6
Current: $0.215
Upside: n/a
Mar 2, 2023
Maintained: Hold
Price Target: $4.7 → $3
Current: $57.32
Upside: n/a
Nov 15, 2022
Downgraded: Hold
Price Target: $4.5
Current: $26.49
Upside: n/a
Apr 29, 2022
Downgraded: Hold
Price Target: $4.7 → $0.16
Current: $0.0001
Upside: n/a
Feb 28, 2022
Reiterated: Buy
Price Target: $84 → $120
Current: $29.40
Upside: n/a